Skip to main content
PMC home page
The World Allergy Organization Journal logoLink to The World Allergy Organization Journal
. 2019 Jun 6;12(5):100035. doi: 10.1016/j.waojou.2019.100035

Helicobacter pylori in relation to asthma and allergy modified by abdominal obesity: The HUNT study in Norway

Eivind Ness-Jensen a,b,c, Arnulf Langhammer a, Kristian Hveem a, Yunxia Lu d,e,∗
PMCID: PMC6555905  PMID: 31194177

Abstract

Objective

It is unknown whether the decreasing prevalence of H. pylori infections is associated with the increase in obesity and asthma and allergy. In this study, we assessed if obesity plays an intermediate role between H. pylori infections and allergy.

Design

A population-based, nested case-control study of 10,005 participants within the second Nord-Trøndelag Health Study (HUNT2), Norway, was performed in 1995–1997. The presence of H. pylori was tested by an enzyme immunoassay Pyloriset EIA-IgG, and weight, height, and waist circumference were measured. Body mass index (BMI) and waist circumference were used as measures of general and abdominal obesity, respectively. Self-reported asthma and allergic diseases were collected through questionnaires. The odds ratios of H. pylori relative to asthma and allergic diseases were estimated by logistic regression models stratified by waist circumference categories.

Results

H. pylori infection was present in 31%, ever asthma was reported in 10.4% and allergic rhinitis in 16.2%. The mean BMI was 26.4 ​kg/m2 and the mean waist circumference was 86.6 ​cm. H. pylori infection was neither associated with asthma nor allergic diseases. However, when stratified by waist circumference, H. pylori infection was associated with 30–40% reduced odds of asthma and 25% reduced odds of allergic diseases in individuals with abdominal obesity (waist circumference ≥86 ​cm in women and ≥96 ​cm in men).

Conclusion

H. pylori infection is associated with reduced risk of asthma and allergy in individuals with abdominal obesity, suggesting a possible causal pathway from reduced H. pylori infections through obesity to increased risk of asthma and allergy.

Keywords: Helicobacter pylori, Asthma, Allergy, Obesity, Abdominal obesity

Introduction

Infection with Helicobacter pylori (H. pylori) is common in humans and associated with socioeconomic status and living conditions in childhood.1 In developed countries, the prevalence of H. pylori infections has rapidly decreased in parallel to economic improvement over the past decades.2 This might be due to improved hygiene and sanitation, less salted food, and possibly increased use of antimicrobial agents.

Interestingly, as the prevalence of H. pylori has declined, there has been a rise in the prevalence of asthma and allergic diseases (e.g., hay fever and atopy) in developed countries.3, 4, 5 Tobacco smoking, air pollution, allergens, microbial infection, and obesity are among the potentially attributable exposures that may cause the increase of asthma and allergic diseases.6, 7 As an indigenous microbiota, the decrease of H. pylori has been postulated to play a role in this increase.8 There have been quite a few epidemiologic studies examining the association between H. pylori and asthma and allergic diseases. The results, however, are largely controversial.9

Parallel to the decrease in H. pylori infections, there has been a global increase of obesity during the past decades.10, 11 Obesity is associated with chronic inflammation which may be involved in the allergic response.12 A positive association between obesity and asthma and allergic diseases has been reported in many studies.13, 14 Moreover, lack of H. pylori infection has been associated with obesity in accumulating studies.15, 16 Thus, there could be an association between H. pylori, obesity, and asthma and allergic diseases, but so far this has not been studied. Whether lack of H. pylori infection leads to increased risk of asthma and allergic diseases and obesity, independent of each other, or the lack of H. pylori infection leads to increased obesity and then increased risk of allergic diseases, as a part of the same causal pathway, is unknown. In this large population-based Norwegian study, we examined the association between H. pylori infection, obesity, and asthma and allergic diseases.

Methods

Study design

In this nested case-control study, data from the second survey of the Nord-Trøndelag Health Study (HUNT2) was used.17 In HUNT2, performed in 1995–1997, all residents of Nord-Trøndelag County aged 20 years and older were invited to answer questionnaires and interviews, participate in clinical examinations, and contribute with biological material. Among 65,237 participants in HUNT2 (69.5% of invited), serum from 10,005 randomly selected individuals were tested for H. pylori.

Study outcome

Asthma and allergy

Asthma and allergy were assessed through self-reported questionnaires in HUNT2. Asthma was defined as present if the participants reported to have or have had asthma (ever), or if they reported to use or have used asthma medication (definition I). To avoid misclassification with chronic obstructive pulmonary disease (COPD) due to tobacco smoking, we also defined asthma as for definition I, but excluding participants that had smoked for more than 10 years (definition II). The participants also reported age of onset of asthma. Allergic rhinitis was defined as present if the participants reported to have hay fever or nasal allergy.

Main exposures

H. pylori

Serological status of H. pylori IgG antibodies was analysed using the commercially available enzyme immunoassay Pylorisert EIA-IgG (Orion Diagnostica, Espoo, Finland) at Levanger Hospital, Norway. Assay for detection of H. pylori was performed in 1998. The cut-off level used for a positive H. pylori IgG was ≥300 U.18

General obesity and abdominal obesity

Trained personnel at the screening stations objectively measured height, weight, and waist circumference during HUNT2. Body mass index (BMI) was calculated by dividing weight in kilograms by height in meters squared (kg/m2) for estimation of general obesity. According to the World Health Organization's definitions, obesity was defined as BMI ≥30 and abdominal obesity as waist circumference ≥86 ​cm in women and ≥96 ​cm in men.

Other factors

The following factors were selected a priori and included in the analyses: sex, age, tobacco smoking, alcohol drinking (monthly frequency of drinking), physical activity (reported hours of physical activity [light and hard] per week in the last year), highest completed education, and family history of asthma and allergy. Except from sex and age, all factors were assessed through self-reported questionnaires. Family history of asthma or allergic rhinitis was reported on first degree relatives (parents, siblings, and children).

Statistical analysis

Logistic regression was used to assess odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between H. pylori, obesity, and asthma and allergy. Separate analyses were performed stratified for waist circumference categories based on the sex-specific intervals: <75, ≥75 to <86, and ≥86 for women; and <88, ≥88 to <96, and ≥96 for men. The fully adjusted analyses were performed with age as a continuous variable, while the other variables were categorized. Tobacco smoking was categorized as never, occasional, and daily. Alcohol drinking was categorized as never, infrequent (once a week or less), and frequent (more than once a week). Physical activity was categorized as inactive (no activity or less than one hour light activity a week), moderately active (1–2 hours light activity or less than 1 hour hard activity a week), and highly active (at least 3 hours light activity or at least 1 hour hard activity a week). Completed education was categorized as primary school, high school, and college/university. In order to entangle the complex relations between H. pylori, obesity and asthma and allergies, we performed a mediation analysis to estimate the indirect effect of obesity relative to the total effect of H. pylori on the outcome of interest. The SAS 9.4 for Window was applied for data management, descriptive statistical analysis and logistic regression. All statistical analysis were two sides with significant level at 0.05.

Ethical approval

The study has ethical approval through the Regional Committee for Medical and Health Research Ethics, Central Norway (2012/1878). In HUNT, all participants gave written informed consent when participating, stating that their data could be used in future medical research.

Results

Characteristics

In the study population, the mean age was 50 years, 54% were women, and 31% were H. pylori positive (Table 1). The mean BMI was 26.4 ​kg/m2 (men:26.4; women; 26.3, respectively) and the mean waist circumference was 86.6 ​cm (men: 92.3; women: 81.6, respectively). Ever having had asthma was reported by 10.4% and after excluding those smoking >10 years, the figure was 5.7%. Hay fever or nasal allergies were reported by 15.1% and allergic rhinitis (including use of anti-allergy medication) were present in 16.2%. In total, 26.5% of the 10,005 participants had asthma or an allergic disease.

Table 1.

Basic characteristics of the randomly selected 10005 HUNT2 participants.

Total Asthma
 Hay fever or nasal allergies Allergic rhinitis Asthma or allergic rhinitis
Definition I Definition II
Total N % N % N % N % N % N %
10005 100 1041 10.40 569 5.69 1507 15.06 1620 16.19 2655 26.54
Sex
 Women 5414 54.11 576 55.33 334 58.70 882 58.53 951 58.70 1488 56.05
 Men 4591 45.89 465 44.67 235 41.30 625 41.47 669 41.30 1167 43.95
Age
 Mean (SD) 50.11 (16.78) 50.11 (17.51) 46.31 (18.81) 46.30 (16.08) 46.54 (16.11) 49.03 (16.97)
 Median (IQR) 48.80 (27.00) 49.40 (29.30) 44.00 (31.30) 43.90 (23.70) 44.30 (24.05) 47.70 (27.20)
 <40 3166 31.64 339 32.56 251 44.11 610 40.48 642 39.63 925 34.84
 40- 2046 20.45 189 18.16 87 15.29 317 21.04 342 21.11 526 19.81
 50- 1796 17.95 165 15.85 74 13.01 242 16.06 270 16.67 439 16.53
 ≥60 2993 29.92 348 33.43 157 27.59 338 22.43 366 22.59 765 28.81
 Missing 4 0.04
H. pylori IgG
 Negative 6924 69.21 711 68.30 418 73.46 1125 74.65 1201 74.14 1854 30.17
 Positive 3081 30.79 330 31.70 151 26.54 382 25.35 419 25.86 801 69.83
Body mass index
 Mean (SD) 26.36 (4.06) 27.19 (4.51) 27.01 (4.40) 26.32 (4.15) 26.39 (4.15) 26.76 (4.31)
 Median (IQR) 25.80 (5.00) 26.50 (6.00) 26.45 (6.10) 25.80 (5.10) 25.90 (5.20) 26.20 (5.40)
 <20 273 2.73 22 2.13 14 2.47 41 2.73 44 2.73 64 2.42
 20- 3666 36.64 313 30.24 177 31.27 560 37.31 594 36.80 887 33.57
 25- 4362 43.60 440 42.51 237 41.87 651 43.37 701 43.43 1149 43.49
 ≥30 1656 16.55 260 25.12 138 24.38 249 16.59 275 17.04 542 20.51
 Missing 48 0.48
Waist circumference (cm)
 Mean (SD) 86.56 (11.86) 89.25 (12.95) 87.71 (12.47) 85.85 (12.10) 86.00 (12.10) 87.64 (12.56)
 Median (IQR) 86.00 (16.00) 89.00 (18.00) 87.00 (18.00) 85.00 (16.00) 86.00 (16.00) 87.00 (18.00)
 Women<75; Men<88 3095 30.93 253 24.56 156 27.76 474 31.83 499 31.17 739 28.14
 75 ​≤ ​Women <86; 88 ​≤ ​Men<96 3493 34.91 315 30.58 180 32.03 535 35.93 575 35.92 885 33.70
 Women≥86; Men≥96 3303 33.01 462 44.85 226 40.21 480 32.24 527 32.92 1002 38.16
 Missing 114 1.14
Tobacco smoking
 No smoking 4112 41.10 380 36.50 380 66.78 703 46.65 742 45.80 1048 39.47
 Smoking occasionally 3057 30.55 355 34.10 140 24.60 452 29.99 488 30.12 822 30.96
 Smoking daily 2831 28.30 306 29.39 49 8.61 352 23.36 390 24.07 785 29.57
 Missing 5 0.05
Alcohol drinking
 Never 2373 23.72 276 26.51 145 25.48 379 25.15 400 24.69 664 25.01
 Infrequent 4572 45.70 454 43.61 259 45.52 724 48.04 776 47.90 1211 45.61
 Frequent 1399 13.98 140 13.45 58 10.19 208 13.80 226 13.95 361 13.60
 Missing 1661 16.60
Physical activity
 Inactive 1709 17.08 195 18.73 83 14.59 224 14.86 249 15.37 464 17.48
 Moderately active 2954 29.53 299 28.72 165 29.00 503 33.38 533 32.90 822 30.96
 Highly active 4234 42.32 428 41.11 257 45.17 678 44.99 723 44.63 1111 41.85
 Missing 1108 11.07
Education
 Primary school 3241 32.39 363 34.87 158 27.77 417 27.67 450 27.78 859 32.35
 High school 3191 31.89 322 30.93 169 29.70 457 30.33 500 30.86 829 31.22
 College/university 3095 30.93 297 28.53 209 36.73 581 38.55 610 37.65 838 31.56
 Missing 478 4.78
Family history of asthma
 No 7963 79.59 636 61.10 299 52.55 599 39.75 1026 63.33 1805 67.98
 Yes 2038 20.37 405 38.90 270 47.45 908 60.25 594 36.67 850 32.02
 Missing 4 0.04
Family history of allergic rhinitis
 No 6927 69.24 577 55.43 347 60.98 945 62.71 670 41.36 1411 53.15
 Yes 3074 30.72 464 44.57 222 39.02 562 37.29 950 58.64 1244 46.85
 Missing 4 0.04
Open in a new tab

Asthma definition I: Asthma or medication for asthma.

Asthma definition II: Definition I, excluding those smoking for more than 10 years.

Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.

SD: standard deviation.

IQR: interquartile range.

Associations

H. pylori infection was not associated with asthma or allergic diseases in general (Table 2), neither using the basic model, adjusting for sex and age, nor using the full model, also adjusting for BMI, tobacco smoking, alcohol drinking, physical activity, education, and family history of asthma and allergic diseases.

Table 2.

Odds ratios (ORs) and 95% confidence intervals (CIs) of H. pylori infection relative to asthma and allergy.

H. pylori infection
Negative
 Positive
 dBasic model
 eFull model
N N OR (95% CI) OR (95% CI)
aAsthma (definition I) 711 330 1.01 (0.87,1.17) 1.00 (0.86,1.17)
 Asthma (onset at age<18) 287 82 0.92 (0.70,1.20) 0.93 (0.71,1.22)
 Asthma (onset at age≥18) 228 141 1.07 (0.85,1.34) 1.08 (0.85,1.36)
bAsthma (definition II) 418 151 0.90 (0.73,1.11) 0.94 (0.76,1.16)
Hay fever or nasal allergies 1125 382 0.91 (0.79,1.04) 0.93 (0.81,1.07)
cAllergic rhinitis 1201 419 0.93 (0.81,1.06) 0.95 (0.83,1.09)
Asthma or allergic rhinitis 1854 801 1.02 (0.92,1.13) 1.03 (0.92,1.14)
Open in a new tab
a

Asthma definition I: Asthma or medication for asthma.

b

Asthma definition II: Definition I, excluding those smoking for more than 10 years.

c

Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.

d

Basic model: Adjusted for sex and age.

e

Full model: Adjusted for sex, age, body mass index, tobacco smoking, alcohol drinking, physical activity, education, and family history of asthma or allergic rhinitis.

Effect modification analysis

However, when stratifying for waist circumference, H. pylori infection was associated with asthma and allergy in individuals with abdominal obesity (waist circumference ≥86 ​cm in women and ≥96 ​cm in men) (Table 3). In abdominal obesity, H. pylori infection was associated with a 40% reduced odds of asthma (definition I) with onset below 18 years of age (fully adjusted OR 0.61, 95% CI 0.37–0.99). H. pylori infection in abdominal obesity was not associated with asthma (definition I) with onset above 18 years of age (fully adjusted OR 0.98, 95% CI 0.71–1.35). Excluding those smoking for more than 10 years (definition II), H. pylori infection in abdominal obesity was associated with a 30% reduced odds of asthma (fully adjusted OR 0.70, 95% CI 0.50–0.97). H. pylori infection in abdominal obesity was also associated with a 25% reduced odds of hay fever or nasal allergies (fully adjusted OR 0.75, 95% CI 0.59–0.95).

Table 3.

Odds ratios (ORs) and 95% confidence intervals (CIs) of H. pylori infection relative to asthma and allergy, stratified by waist circumference.

Waist circumference (cm): women<75; men<88
 Waist circumference (cm): 75 ≤ women<86; 88 ≤ men<96
 Waist circumference (cm): women≥86; men≥96
H. pylori infection
 H. pylori infection
 H. pylori infection
Negative
 Positive
 Basic modeld
 Full Model
 Negative
 Positive
 Basic modeld
 Full Model
 Negative
 Positive
 Basic modeld
 Full Model
N N OR (95%CI) OR (95%CI) N N OR (95%CI) OR (95%CI) N N OR (95%CI) OR (95%CI)
Asthma (definition I)a 193 60 0.97 (0.70,1.34) 0.93 (0.67,1.30) 213 102 1.16 (0.90,1.52) 1.17 (0.89,1.53) 297 165 0.91 (0.73,1.14) 0.92 (0.73,1,15)
 Asthma (onset at age<18) 102 24 0.97 (0.60,1.57) 0.97 (0.59,1.59) 87 31 1.19 (0.77,1.85) 1.24 (0.77,1.94) 90 24 0.58 (0.36,0.93)∗ 0.61 (0.37,0.99)∗
 Asthma (onset at age≥18) 37 25 1.55 (0.89,2.70) 1.46 (0.83,2.57) 67 36 1.02 (0.66,1.57) 1.00 (0.64,1.55) 119 80 0.99 (0.73,1.35) 0.98 (0.71,1.35)
Asthma (definition II)b 125 31 1.00 (0.65,1.54) 1.05 (0.67,1.63) 127 53 1.12 (0.79,1.59) 1.23 (0.85,1.77) 161 65 0.69 (0.50,0.94)∗ 0.70 (0.50,0.97)∗
Hay fever or nasal allergies 378 96 0.97 (0.75,1.27) 0.98 (0.74,1.29) 388 147 1.07 (0.86,1.33) 1.09 (0.86,1.37) 346 134 0.72 (0.57,0.91)∗ 0.75 (0.59,0.95)∗
Allergic rhinitisc 399 100 0.96 (0.74,1.25) 0.97 (0.74,1.27) 417 158 1.06 (0.85,1.31) 1.07 (0.86,1.34) 372 155 0.77 (0.62,0.96)∗ 0.80 (0.64,1.01)
Asthma or allergic rhinitis 571 168 0.99 (0.80,1.223) 0.99 (0.79,1.23) 617 268 1.09 (0.91,1.30) 1.10 (0.92,1.32) 644 358 0.96 (0.81,1.13) 0.98 (0.83, 1.16)
Open in a new tab
a

Asthma definition I: Asthma or medication for asthma.

b

Asthma definition II: Definition I, excluding those smoking for more than 10 years.

c

Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.

d

Basic model: Adjusted for sex and age.

∗

p < 0.05.

Discussion

In the present study we found no association between H. pylori infection and asthma or allergic diseases in general. However, H. pylori infection was associated with a reduced risk of asthma and allergy in individuals with abdominal obesity, suggesting a possible causal pathway from reduced H. pylori infections through obesity to increased asthma and allergy.

The strengths of this study include the population-based design, large sample size, and random selection of participants where H. pylori status was assessed, reducing the risk of selection bias and chance findings. In addition, the HUNT study assessed a number of high quality variables that made adjustments for important confounders possible. The objective measurements of BMI and waist circumference are of great importance when assessing obesity. One weakness in this study is the self-reported asthma and allergy. This might introduce misclassification, mainly towards COPD. This is partly avoided by using a definition of asthma excluding participants that had smoked for more than 10 years (definition II) and stratified asthma with onset below 18 years of age (childhood asthma). Another weakness is the lack of data on cagA status, which has been regarded as an important factor in H. pylori infection that is negatively associated with asthma and allergy.19 As this is an observational study, causal associations cannot be claimed based on concurrent measurements of outcomes, exposures, and confounders.

A potential inverse relationship between H. pylori and asthma and allergy has been widely reported, although the results are controversial.20, 21, 22, 23, 24, 25 In the largest meta-analysis including 19 studies,9 an inverse association between H. pylori and asthma was demonstrated based on nine cross-sectional studies (pooled OR 0.84, 95% CI 0.74–0.96), but the pooled OR was not statistically significant in seven case-control studies (pooled OR 0.82, 95% CI 0.53–1.27) or three prospective cohort studies (pooled OR 0.82, 95% CI 0.53–1.27). Interestingly, the meta-analysis showed an inverse association in children (pooled OR 0.81, 95% CI 0.72–0.91) but not in adults (pooled OR 0.88, 95% CI 0.71–1.08), which is partially consistent with our results. The benefit of H. pylori in early life has been observed in quite a few studies,20, 21, 22, 26, 27 but at a late-in-life cost (e.g., H. pylori is a risk factor of peptic ulcer disease and stomach cancer).28 However, in the present study, such an inverse association were only identified in abdominally obese persons who had asthma or allergic rhinitis in their early life. This result may indicate an intriguing and complex relationship between H. pylori, obesity, and asthma and allergy.

A possible inverse relationship between exposure to H. pylori and the occurrence of obesity has been addressed as well,15, 29, 30, 31 although the results are still controversial.32 Moreover, whether H. pylori infection plays a role only in childhood or adult adiposity is unclear. As both H. pylori and obesity have been associated with asthma and allergic disease, the role of the two factors needs to be further clarified. Whether one factor is another factor's confounder, effect modifier or intermediate is unknown. In the present study, there was an association between H. pylori and asthma and allergic disease in abdominally obese participants, but this association disappeared in the non-abdominally obese population. This indicates that obesity may play a role as an effect modifier between H. pylori and asthma and allergy. As the analyses were based on cross-sectional data, potential obesity could be an intermediate in the pathway from H. pylori to asthma and allergy.

The underlying mechanisms between H. pylori, obesity, and asthma and allergy are plausible. H. pylori are one of the most common bacteria in humans, with prevalence rates of H. pylori in human populations ranging from 20 to 50%.33, 34 In the past decades, infection with H. pylori substantially declined due to improved living conditions and increased use of antibiotics. Individuals exposed to H. pylori in early childhood are prone to have a decreased appetite and food intake due to defective signalling of appetite- and satiety-related hormones in the stomach, e.g., ghrelin and leptin.20, 35 Hormone ghrelin exerts long-term appetite stimulating behaviour through its receptors in the hypothalamic paraventricular and arcuate nuclei.36, 37 Decreased exposure to H. pylori results in increased ghrelin and downregulated gastric leptin in children and in adults, thus increasing appetite stimulating behaviour and then leading to obesity. Interestingly, ghrelin has been associated with abdominal adiposity through regulation of lipid storage in abdominal white adipose tissue38; higher leptin levels has also been associated with abdominal obesity in quite a few studies.39, 40 In addition, H. pylori could be an indicator for changes in the gut microbiome. It reflects the complex interaction between microbes and the immune system.41, 42 When H. pylori are eradicated (other microbes will be influenced as well), the inner balance of microbes, appetite-related hormones, and the immune system will be broken, and then the person will become obese. The cytokines stimulated by chronic inflammation in the obese population will further trigger asthma and allergy. On the other hand, in obese persons, the cytokines may be supressed by infection with H. pylori. A protective association of H. pylori with asthma and allergic disease through obesity is plausible. This hypothesis aligns with the present study.

Another potential pathway is through Th1 and Th2 lymphocytes. A growing body of evidence indicates a preventive action of H. pylori to asthma and allergy probably through the gastric recruitment of regulatory T cells.43 It is well recognized that infections with H. pylori can trigger a Th1-mediated immune response.43 Activation of Th1 then suppresses the Th2 responses. The predominant activation of Th1 lymphocytes by H. pylori leads to the production of interferon gamma, interleukin 12, and tumor necrosis factor alpha in the stomach.44 Eradication of H. pylori will lead to inadequate Th1 response that might result in an overactive Th2 response with production of cytokines, including interleukins 4, 5, and 13, which are associated with the promotion of IgE and eosinophilic responses, and eventually allergies. The inverse association between H. pylori and asthma and allergic disease was first observed in 1989 with the “hygiene hypothesis”.45 It was based on observations of declining prevalence of allergic rhinitis with increasing number of older siblings. It suggested a preventive effect of transmitted infections in early childhood from older siblings. Exposure to infectious agents might educate the immune system and provide protection against allergic rhinitis. However, how obesity plays a role in this pathway is unclear. As the benefit of H. pylori was only shown in the obese population, the present study might suggest that the immune system educated by infection with H. pylori may be more alert to asthma and allergy in those obese.

In conclusion, this large population-based study found reduced risk of asthma and allergy with H. pylori infection in individuals with abdominal obesity. This suggests a possible protective effect of H. pylori infection in the development of asthma and allergy and possibly a causal pathway from reduced H. pylori infections through obesity to increased asthma and allergy.

Declarations

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

YXL proposed the conception of the study, designed the study based on the HUNT cohort, performed the data analysis and wrote the paper; ENJ designed the study, collected the data and participated in the analysis and wrote the paper; AL contributed specifically to the definition of asthma and allergic diseases using data from the HUNT cohort. He also contributed to the results interpretation and wrote the paper; KH designed the study, collected the data and contributed to results interpretation and manuscript writing. All authors of this paper have directly participated in the planning, execution, or analysis of the study, and have read and approved the final version submitted.

Authors' information

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Results from the HUNTs have been published in numerous studies. Due to the current ethical issues, data was not supposed to be shared by the general public. Please contact the authors for data inquiry.

Funding

Not applicable.

Acknowledgement

The Nord-Trøndelag Health Study (The HUNT Study) is a collaboration between HUNT Research Centre (Faculty of Medicine, NTNU, Norwegian University of Science and Technology), Nord-Trøndelag County Council, Central Norway Health Authority, and the Norwegian Institute of Public Health.

Contributor Information

Eivind Ness-Jensen, Email: eivind.ness-jensen@ntnu.no.

Arnulf Langhammer, Email: arnulf.langhammer@ntnu.no.

Kristian Hveem, Email: Kristian.Hveem@ntnu.no.

Yunxia Lu, Email: yunxia.lu@uci.edu.

References

  • 1.Webb P.M., Knight T., Greaves S. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ. 1994;308(6931):750–753. doi: 10.1136/bmj.308.6931.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Asaka M., Kimura T., Kudo M. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102(3):760–766. doi: 10.1016/0016-5085(92)90156-s. [DOI] [PubMed] [Google Scholar]
  • 3.Asher M.I., Montefort S., Bjorksten B. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–743. doi: 10.1016/S0140-6736(06)69283-0. [DOI] [PubMed] [Google Scholar]
  • 4.Gupta R., Sheikh A., Strachan D.P., Anderson H.R. Time trends in allergic disorders in the UK. Thorax. 2007;62(1):91–96. doi: 10.1136/thx.2004.038844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jackson K.D., Howie L.D., Akinbami L.J. Trends in allergic conditions among children: United States, 1997-2011. NCHS Data Brief. 2013;(121):1–8. [PubMed] [Google Scholar]
  • 6.Kim B.J., Lee S.Y., Kim H.B., Lee E., Hong S.J. Environmental changes, microbiota, and allergic diseases. Allergy Asthma Immunol Res. 2014;6(5):389–400. doi: 10.4168/aair.2014.6.5.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Subbarao P., Becker A., Brook J.R. Epidemiology of asthma: risk factors for development. Expert Rev Clin Immunol. 2009;5(1):77–95. doi: 10.1586/1744666X.5.1.77. [DOI] [PubMed] [Google Scholar]
  • 8.Taube C., Muller A. The role of Helicobacter pylori infection in the development of allergic asthma. Expert Rev Respir Med. 2012;6(4):441–449. doi: 10.1586/ers.12.40. [DOI] [PubMed] [Google Scholar]
  • 9.Wang Q., Yu C., Sun Y. The association between asthma and Helicobacter pylori: a meta-analysis. Helicobacter. 2013;18(1):41–53. doi: 10.1111/hel.12012. [DOI] [PubMed] [Google Scholar]
  • 10.Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491–497. doi: 10.1001/jama.2012.39. [DOI] [PubMed] [Google Scholar]
  • 11.Parikh N.I., Pencina M.J., Wang T.J. Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med. 2007;120(3):242–250. doi: 10.1016/j.amjmed.2006.06.004. [DOI] [PubMed] [Google Scholar]
  • 12.Divella R., De Luca R., Abbate I., Naglieri E., Daniele A. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016;7(15):2346–2359. doi: 10.7150/jca.16884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Weinmayr G., Forastiere F., Buchele G. Overweight/obesity and respiratory and allergic disease in children: international study of asthma and allergies in childhood (ISAAC) phase two. PLoS One. 2014;9(12):e113996. doi: 10.1371/journal.pone.0113996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Raj D., Kabra S.K., Lodha R. Childhood obesity and risk of allergy or asthma. Immunol Allergy Clin North Am. 2014;34(4):753–765. doi: 10.1016/j.iac.2014.07.001. [DOI] [PubMed] [Google Scholar]
  • 15.Wu M.S., Lee W.J., Wang H.H., Huang S.P., Lin J.T. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165(13):1552–1555. doi: 10.1001/archinte.165.13.1552. [DOI] [PubMed] [Google Scholar]
  • 16.Lender N., Talley N.J., Enck P. Review article: associations between Helicobacter pylori and obesity–an ecological study. Aliment Pharmacol Ther. 2014;40(1):24–31. doi: 10.1111/apt.12790. [DOI] [PubMed] [Google Scholar]
  • 17.Krokstad S., Langhammer A., Hveem K. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42(4):968–977. doi: 10.1093/ije/dys095. [DOI] [PubMed] [Google Scholar]
  • 18.Hveem K., Kruger O. The prevalence of Helicobacter pylori in a large population based study related to transmission, cardiovascular disease and the level of ultrasensitive Crp. the North-Trondelag health survey (HUNT), Norway. Gastroenterology. 2003;124(4):A625. [Google Scholar]
  • 19.Chen Y., Segers S., Blaser M.J. Association between Helicobacter pylori and mortality in the NHANES III study. Gut. 2013;62(9):1262–1269. doi: 10.1136/gutjnl-2012-303018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chen Y., Blaser M.J. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis. 2008;198(4):553–560. doi: 10.1086/590158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chen Y., Blaser M.J. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007;167(8):821–827. doi: 10.1001/archinte.167.8.821. [DOI] [PubMed] [Google Scholar]
  • 22.Fouda E.M., Kamel T.B., Nabih E.S., Abdelazem A.A. Helicobacter pylori seropositivity protects against childhood asthma and inversely correlates to its clinical and functional severity. Allergol Immunopathol (Madr) 2018;46(1):76–81. doi: 10.1016/j.aller.2017.03.004. [DOI] [PubMed] [Google Scholar]
  • 23.Khamechian T., Movahedian A.H., Ebrahimi Eskandari G., Heidarzadeh Arani M., Mohammadi A. Evaluation of the correlation between childhood asthma and Helicobacter pylori in Kashan. Jundishapur J Microbiol. 2015;8(6):e17842. doi: 10.5812/jjm.8(6)2015.17842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Reibman J., Marmor M., Filner J. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One. 2008;3(12):e4060. doi: 10.1371/journal.pone.0004060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Annagur A., Kendirli S.G., Yilmaz M., Altintas D.U., Inal A. Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae and Helicobacter pylori. J Trop Pediatr. 2007;53(5):313–318. doi: 10.1093/tropej/fmm040. [DOI] [PubMed] [Google Scholar]
  • 26.Arnold I.C., Hitzler I., Muller A. The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol. 2012;2:10. doi: 10.3389/fcimb.2012.00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Karakullukcu A., Tokman H.B., Nepesov S. The protective role of Helicobacter pylori neutrophil-activating protein in childhood asthma. Allergol Immunopathol (Madr) 2017;45(6):521–527. doi: 10.1016/j.aller.2017.01.008. [DOI] [PubMed] [Google Scholar]
  • 28.Atherton J.C., Blaser M.J. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Investig. 2009;119(9):2475–2487. doi: 10.1172/JCI38605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lane J.A., Murray L.J., Harvey I.M., Donovan J.L., Nair P., Harvey R.F. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33(8):922–929. doi: 10.1111/j.1365-2036.2011.04610.x. [DOI] [PubMed] [Google Scholar]
  • 30.Moran-Lev H., Lubetzky R., Mandel D., Yerushalmy-Feler A., Cohen S. Inverse correlation between Helicobacter pylori colonization and pediatric overweight: a preliminary study. Child Obes. 2017;13(4):267–271. doi: 10.1089/chi.2016.0275. [DOI] [PubMed] [Google Scholar]
  • 31.Vo H.D., Goli S., Gill R. Inverse correlation between Helicobacter pylori colonization and obesity in a cohort of inner city children. Helicobacter. 2015;20(1):64–68. doi: 10.1111/hel.12154. [DOI] [PubMed] [Google Scholar]
  • 32.den Hollander W.J., Broer L., Schurmann C. Helicobacter pylori colonization and obesity - a Mendelian randomization study. Sci Rep. 2017;7(1):14467. doi: 10.1038/s41598-017-14106-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Peleteiro B., Bastos A., Ferro A., Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698–1709. doi: 10.1007/s10620-014-3063-0. [DOI] [PubMed] [Google Scholar]
  • 34.Mentis A., Lehours P., Megraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter. 2015;20(Suppl 1):1–7. doi: 10.1111/hel.12250. [DOI] [PubMed] [Google Scholar]
  • 35.Klok M.D., Jakobsdottir S., Drent M.L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007;8(1):21–34. doi: 10.1111/j.1467-789X.2006.00270.x. [DOI] [PubMed] [Google Scholar]
  • 36.Jeffery P.L., McGuckin M.A., Linden S.K. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol. 2011;17(10):1249–1260. doi: 10.3748/wjg.v17.i10.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Weigt J., Malfertheiner P. Influence of Helicobacter pylori on gastric regulation of food intake. Curr Opin Clin Nutr Metab Care. 2009;12(5):522–525. doi: 10.1097/MCO.0b013e32832eb56e. [DOI] [PubMed] [Google Scholar]
  • 38.Davies J.S., Kotokorpi P., Eccles S.R. Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol. 2009;23(6):914–924. doi: 10.1210/me.2008-0432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Maruyama Y., Mizuguchi M., Yaginuma T. Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury. Spinal Cord. 2008;46(7):494–499. doi: 10.1038/sj.sc.3102171. [DOI] [PubMed] [Google Scholar]
  • 40.Vasilenko M.A., Kirienkova E.V., Skuratovskaia D.A., Zatolokin P.A., Mironyuk N.I., Litvinova L.S. The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity. Dokl Biochem Biophys. 2017;475(1):271–276. doi: 10.1134/S160767291704010X. [DOI] [PubMed] [Google Scholar]
  • 41.Daugule I., Zavoronkova J., Santare D. Helicobacter pylori and allergy: update of research. World J Methodol. 2015;5(4):203–211. doi: 10.5662/wjm.v5.i4.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Blaser M.J., Chen Y., Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut. 2008;57(5):561–567. doi: 10.1136/gut.2007.133462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lankarani K.B., Honarvar B., Athari S.S. The mechanisms underlying Helicobacter pylori-mediated protection against allergic asthma. Tanaffos. 2017;16(4):251–259. [PMC free article] [PubMed] [Google Scholar]
  • 44.Amedei A., Codolo G., Del Prete G., de Bernard M., D'Elios M.M. The effect of Helicobacter pylori on asthma and allergy. J Asthma Allergy. 2010;3:139–147. doi: 10.2147/JAA.S8971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Strachan D.P. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259–1260. doi: 10.1136/bmj.299.6710.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Results from the HUNTs have been published in numerous studies. Due to the current ethical issues, data was not supposed to be shared by the general public. Please contact the authors for data inquiry.

Articles from The World Allergy Organization Journal are provided here courtesy of World Allergy Organization

RESOURCES